A Randomised, Open-label, Parallel Group, Multi-center Study Using OCT to Comparing the Efficacy and Safety of Ticagrelor With Clopidogrel in the Prevention of Subclinical Thrombus in Patients After Drug-eluting Stent Implantation
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2018
Price : $35 *
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 20 Mar 2018 Status changed from recruiting to completed.
- 31 Dec 2015 Planned End Date changed from 1 May 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov record.
- 15 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.